Skip to content
10-Q

Quarterly Report

INNOVUS PHARMACEUTICALS, INC.

0001437749-19-016550

← back to feed
Filed
Aug 13, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 6, 2019 2.6M sh
Capex Q2 2019 · Jun 30, 2019 $16K
Capex restated Q2 2019 · Jun 30, 2018 $135K
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$1.36M
Operating Cash Flow restated Q2 2019 · Jun 30, 2018 −$3.46M
Short Term Debt Q2 2019 · Jun 30, 2019 $2.32M
Short Term Debt Q2 2019 · Dec 31, 2018 $3.07M
Stockholders Equity Q2 2019 · Jun 30, 2019 $46K
Stockholders Equity Q2 2019 · Mar 31, 2019 $1.06M
Stockholders Equity Q2 2019 · Dec 31, 2018 $109K
Stockholders Equity restated Q2 2019 · Jun 30, 2018 $1.17M
Stockholders Equity Q2 2019 · Mar 31, 2018 $2.71M
Stockholders Equity restated Q2 2019 · Dec 31, 2017 $903K
Current Liabilities Q2 2019 · Jun 30, 2019 $7.88M
Current Liabilities Q2 2019 · Dec 31, 2018 $7.35M
Total Liabilities Q2 2019 · Jun 30, 2019 $10.79M
Total Liabilities Q2 2019 · Dec 31, 2018 $10.02M
Current Assets Q2 2019 · Jun 30, 2019 $5.46M
Current Assets Q2 2019 · Dec 31, 2018 $5.02M
Total Assets Q2 2019 · Jun 30, 2019 $10.84M
Total Assets Q2 2019 · Dec 31, 2018 $10.13M
Sga Expense Q2 2019 · Jun 30, 2019 $2.72M
Sga Expense Q2 2019 · Jun 30, 2019 $5.16M
Sga Expense restated Q2 2019 · Jun 30, 2018 $1.92M
Sga Expense restated Q2 2019 · Jun 30, 2018 $3.62M
Rd Expense Q2 2019 · Jun 30, 2019 $91K
Rd Expense Q2 2019 · Jun 30, 2019 $148K
Rd Expense restated Q2 2019 · Jun 30, 2018 $23K
Rd Expense restated Q2 2019 · Jun 30, 2018 $34K
Net Income Q2 2019 · Jun 30, 2019 −$1.76M
Net Income Q2 2019 · Jun 30, 2019 −$3.75M
Net Income Q2 2019 · Mar 31, 2019 −$1.99M
Net Income restated Q2 2019 · Jun 30, 2018 −$1.84M
Net Income restated Q2 2019 · Jun 30, 2018 −$3.67M
Net Income Q2 2019 · Mar 31, 2018 −$1.83M
Operating Income Q2 2019 · Jun 30, 2019 −$1.18M
Operating Income Q2 2019 · Jun 30, 2019 −$2.68M
Operating Income restated Q2 2019 · Jun 30, 2018 −$1.5M
Operating Income restated Q2 2019 · Jun 30, 2018 −$2.83M
Gross Profit Q2 2019 · Jun 30, 2019 $4.49M
Gross Profit Q2 2019 · Jun 30, 2019 $8.08M
Gross Profit Q2 2019 · Jun 30, 2018 $5.97M
Gross Profit Q2 2019 · Jun 30, 2018 $9.65M
Cost Of Revenue Q2 2019 · Jun 30, 2019 $2.36M
Cost Of Revenue Q2 2019 · Jun 30, 2019 $4.13M
Cost Of Revenue Q2 2019 · Jun 30, 2018 $1.34M
Cost Of Revenue Q2 2019 · Jun 30, 2018 $2.2M
Revenue Q2 2019 · Jun 30, 2019 $6.85M
Revenue Q2 2019 · Jun 30, 2019 $12.21M
Revenue Q2 2019 · Jun 30, 2018 $7.31M
Revenue Q2 2019 · Jun 30, 2018 $11.86M